Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Medartis' IPO CHF142.6 million on SIX Swiss Exchange
Context
Founded in 1997 by Dr. h.c. Thomas Straumman, Medartis Holding AG headquartered in Basel, Switzerland, is a leading manufacturer and provider of medical devices for internal surgical bone fixation.
Medartis specializes in fixation solutions that comprise technical high-precision titanium screws, plates, and surgical instruments for bone fractures fixation and osteotomies of the hand, wrist, elbow, foot, ankle as well as the head.
The company sells its products in 44 countries - including Switzerland, Germany, France, the United States, Japan, Australia and Brazil - directly through its headquarters and 11 subsidiaries, and via distributors.
The funds will in particular help intensify commercialization efforts in the US in order to accelerate growth and increase the market share as well as sustain the commercial launch of products in new territories, including Japan and China.
Transaction highlights
Bryan, Garnier & Co acted as Joint Global Coordinator and Joint Bookrunner on this landmark Swiss IPO.
Offer multiple times over-subscribed across the price range, given strong demand across Switzerland, Continental Europe, UK and the U.S.
Final offer price of CHF48 per share, approximate mid-point of CHF44 - CHF54 price range.
The offering of approximately CHF123.9 million (CHF142.6 million including fully exercised 15% over-allotment shares) consisted of ca. 2.99 million newly issued shares.
Implied market cap of CHF563 million at IPO.
Thomas Straumann, Founder and Chairman of Medartis Holding AG: "We are particularly pleased with the work Bryan, Garnier & Co has done on our IPO. The Bryan, Garnier team truly understood our business and was able to communicate what makes Medartis unique to investors. Their reach into the leading institutions across Europe, the UK, the US, and Switzerland was impressive, and I and the management are very happy with the shareholder base we have to commence life with as a public company. I would recommend Bryan, Garnier & Co to all aspiring IPO companies."
About Medartis
Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures and osteotomies for the craniofacial region as well as for upper and lower extremities. Medartis employs over 480 individuals across its 11 locations, and Medartis products are sold in 44 countries globally. For patients’ welfare, Medartis is committed to providing surgeons and operating theatre personnel with the most innovative titanium implants and instruments as well as best in class services that represent advances in osteosynthesis.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Media & Telecoms, Healthcare, Smart Industries & Energy, Consumer, Brands & Retail and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Zurich and New York. The firm is a member of the London Stock Exchange and Euronext.
Deal team
Olivier Garnier
Managing Partner
T: +33 1 56 68 75 29
Pierre Kiecolt-Wahl
Managing Director
T: +33 1 56 68 75 17
Dr. Anne Moore
Vice President
T: +33 1 56 68 75 39
Jean de Pracomtal
Associate
T: +33 1 56 68 75 38
Rémi Negre
Analyst
T: +33 1 70 36 57 48
In the News
-
Bryan, Garnier & Co acts as Sole Financial Advisor to IK Investment Partners on its acquisition of Recocash
-
Bryan, Garnier & Co acts as Sole Financial Advisor to the Belgian consultancy firm Intys on its equity investment from Omnes
-
Bryan, Garnier & Co acts as Sole Financial Advisor to the audio tech company Arturia on its capital reorganisation led by EMZ Partners
-
Bryan, Garnier & Co acts as Sole Financial Advisor to drone software leader Unifly on a €17 million capital raise
-
Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance